Immunosuppressant Combined With Pirfenidone in CTD-ILD

Clinical trial NCT04928586 · UNKNOWN

Trial details

NCT number: NCT04928586
Sponsor: Qilu Hospital of Shandong University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Pirfenidone Connective Tissue Diseases Interstitial Lung Disease

Start date: 2019-08-16
Primary completion: 2024-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.